Obesity is increasingly recognized as a global pandemic that threatens the health of millions of people. Obesity is considered to be an important cardiovascular risk factor, but there is increasing evidence that patients with elevated body mass index may be better off than others if they develop cardiovascular or renal disease. This phenomenon has been described as the "obesity paradox" or "reverse epidemiology." This article reviews some recent publications that have studied this phenomenon as it relates to heart failure, coronary artery disease, peripheral arterial disease, kidney disease, and a cohort of patients undergoing nonbariatric surgery.
SUMMARYMany fadors influence whether a person will develop coronary heart disease. Genetic predisposition, gender and advanced age are recognized risk factors for the development of coronary heart disease over which we have little control. On the other hand, high serum cholesterol, cigarette smoking, high blood pressure, excessive body weight and long-term physical inactivity are key risk factors over which we have considerable control. In many cases cardiac risk factors can be modified without resorting to pharmacological intervention. Current evidence suggests that individuals who follow a diet which is low in saturated fats and cholesterol, lose weight, stop cigarette smoking and take regular aerobic exercise will significantly reduce their risk of developing coronary heart disease. In addition, patients who already have evidence of coronary heart disease may improve their symptoms and prognosis by similar life-style changes. In the first of two parts, we review the role of exercise in modifying cardiac risk factors.
T H E ROLE OF EXERCISE TRAININGThere is evidence that vigorous activity at work or during leisure time requiring an energy expenditure of 7.5 kcals per min or greater than 65% maximal oxygen uptake (VO, max) and maintained for at least three periods of 20 min each week (I), reduces rates of cardiovascular disease (2, 3). The relationship between physical activity and coronary heart disease (CHD) has been reviewed, studies with good designs and methods demonstrating a significant inverse relation between physical activity and CHD (4, 5). Overall,
Patient: Female, 50Final Diagnosis: Transverse cerebral venous sinus thrombosisSymptoms: Headache, diplopia, nausea, vomitingMedication: —Clinical Procedure: —Specialty: NeurologyObjective:Rare diseaseBackground:Cerebral venous sinus thrombosis (CVST) is an uncommon cause of stroke. CVST can be caused by systemic conditions as well as mechanical factors that reduce blood flow to promote thrombosis. These can include hormonal therapies, pregnancy, malignancy, genetic conditions. trauma, neurosurgical procedures, and adjacent infections (mostly mastoiditis). This case report describes a patient with right transverse sinus thrombosis with no prior risk factors.Case Report:A 50-year-old female with no risk factors presented with complaints of headache associated with diplopia for 2 weeks. She did not have any other neurologic signs or symptoms. The patient initially underwent a cerebral magnetic resonance imaging that revealed right transverse sinus thrombosis. She underwent an extensive procoagulant workup and was found to have an increased factor VIII level. All other workups were negative. The patient was started on heparin infusion and bridged to coumadin to achieve a therapeutic international normalized ratio. The patient had improvement in her headache symptoms and was discharged to be followed as an outpatient.Conclusions:We report a case of right transverse sinus thrombosis in a patient with increased factor VIII levels. It is prudent to promptly diagnose cerebral sinus venous thrombosis and start antithrombotic treatment for complete resolution of symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.